NCT00189956 Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine. Status COMPLETED Phase PHASE2
NCT00189943 Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects Status COMPLETED Phase PHASE1
NCT00123396 VHA Clinicians and Bioterror Events: Interactive Web-based Learning Status COMPLETED Phase NA
NCT00103584 Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers Status UNKNOWN Phase PHASE1/PHASE2
NCT00079820 Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults Status COMPLETED Phase PHASE1
NCT00053508 Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination Status TERMINATED Phase PHASE2
NCT00053495 Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination Status COMPLETED Phase PHASE2
NCT00053482 Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults Status COMPLETED Phase PHASE2
NCT00050505 Expanded Dryvax Dilution Study in Previously Vaccinated Adults Status COMPLETED Phase PHASE2
NCT00042094 Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax® Status COMPLETED Phase PHASE1
NCT00038987 Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT Status COMPLETED Phase PHASE1/PHASE2
NCT00026611 A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults Status COMPLETED Phase PHASE2